IPP Bureau
Unichem Labs receive ANDA approval for Metformin Hydrochloride
By IPP Bureau - August 13, 2021
It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Syngene sets up microbial facility as it expands biopharma-manufacturing capacity
By IPP Bureau - August 13, 2021
It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies
USFDA grants distinct indication for Chronic Sleep Disorder
By IPP Bureau - August 13, 2021
Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder
Sun Pharma Speciality business looks encouraging: HDFC Securities
By IPP Bureau - August 13, 2021
Winlevi, the recently added anti-acne product with a new mechanism of action and broad-based use (vs Absorica), will further boost the derma portfolio and Speciality business growth
Labcorp, a leader in women’s heath solutions acquires Ovia Health
By IPP Bureau - August 13, 2021
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Wockhardt to manufacture and supply Sputnik V
By IPP Bureau - August 13, 2021
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
JB Chemicals & Pharmaceuticals PAT at Rs. 118.9 cr for Q1 FY22
By IPP Bureau - August 13, 2021
Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21
Ind-Swift Laboratories PAT at Rs 18.80 cr for Q1FY22
By IPP Bureau - August 13, 2021
EPS stood at Rs 3.18
Kovai Medical Center & Hospital PAT at Rs 35.22 cr. for Q1FY22
By IPP Bureau - August 13, 2021
EPS at Rs 32.19
HCG Q1 revenue at Rs 326.58 cr. 67 per cent increase YoY
By IPP Bureau - August 13, 2021
Substantial reduction in losses
Indian pharma market grew by 13.7% in July 2021: Ind-Ra
By IPP Bureau - August 12, 2021
Demand normalisation post the second wave contributed to the steady growth
Mangalam Drugs signs tech transfer agreement with Nigerian pharma company
By IPP Bureau - August 12, 2021
Anti-malaria API facility will be operational in 15-18 months
Aster DM Healthcare PAT at Rs 44.47 crores for Q1FY22
By IPP Bureau - August 12, 2021
Income declines marginally
Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
By IPP Bureau - August 12, 2021
It’s an AB-rated generic therapeutic version of Durezol
KK Pant is the new NPPA chairman
By IPP Bureau - August 12, 2021
It plays a pivotal role in monitoring pharmaceutical pricing
